A phase III randomized trial of LV5FU2+CPT-11 vs. LV5FU2 alone in adjuvant high risk colon cancer (FNCLCC Accord02 / FFCD9802) - Ychou, M; Raoul, J; Douillard, J (Journal of Clinical Oncology, 2005)
(Suppl 16, Part I of II):